Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Prete A, Lanino E, Saglio F, Biffi A, Calore E, Faraci M, Rondelli R, Favre C, Zecca M, Casazza G, Porta F, Luksch R, Cesaro S, Rabusin M, Parasole R, Mura RM, Lo Nigro L, Leardini D, Pagliara D, Locatelli F, Fagioli F; AIEOP-BMT Group.
Prete A, et al.
Transplant Cell Ther. 2024 May;30(5):530.e1-530.e8. doi: 10.1016/j.jtct.2024.03.002. Epub 2024 Mar 7.
Transplant Cell Ther. 2024.
PMID: 38460729
Free article.
Clinical Trial.